Search results for "PIDE"

showing 10 items of 6055 documents

The Northern Bolivian Altiplano: a region highly endemic for human fascioliasis.

1999

The worldwide importance of human infection by Fasciola hepatica has been recognized in recent years. The endemic region between Lake Titicaca and the valley of La Paz, Bolivia, at 3800-4100 m altitude, presents the highest prevalences and intensities recorded. Large geographical studies involving Lymnaea truncatula snails (malacological, physico-chemical, and botanic studies of 59, 28 and 30 water bodies, respectively, inhabited by lymnaeids; environmental mean temperature studies covering a 40-year period), livestock (5491 cattle) and human coprological surveys (2723 subjects, 2521 of whom were school children) were conducted during 1991-97 to establish the boundaries and distributional c…

BoliviaFascioliasisAdolescentEndemic DiseasesPopulationlaw.inventionFecesAltitudelawparasitic diseasesPrevalenceFasciola hepaticaAnimalsHumanseducationChildGalba truncatulaLymnaeaeducation.field_of_studySheepbiologybusiness.industryEcologyAltitudePublic Health Environmental and Occupational HealthFasciola hepaticabiology.organism_classificationInfectious DiseasesGeographyTransmission (mechanics)Period (geology)ParasitologyLivestockCattleTrematodabusinessEpidemiologic MethodsTropical medicineinternational health : TMIH
researchProduct

Sheep and Cattle Reservoirs in the Highest Human Fascioliasis Hyperendemic Area: Experimental Transmission Capacity, Field Epidemiology, and Control …

2020

The Northern Bolivian Altiplano is the human fascioliasis hyperendemic area where the highest prevalences and intensities of infection by Fasciola hepatica in humans have been reported. Four animal species are the reservoir species for F. hepatica in this area, namely, sheep, cattle, pigs, and donkeys. Livestock for the Aymara inhabitants is crucial because vegetable cultures are not viable due to the inhospitality of the very high altitude of 3,820–4,100 m. A One Health initiative has been implemented in this area in recent years, as the first such control action in a human endemic area ever. Among the different control axes included, special focus is devoted to the two main reservoirs she…

BoliviaVeterinary medicine040301 veterinary sciencesRange (biology)reservoirslaw.invention0403 veterinary science03 medical and health scienceslawHepaticaparasitic diseasesFasciola hepaticasheep and cattleFecesOriginal Research030304 developmental biologyGalba truncatula0303 health scienceslcsh:Veterinary medicineGeneral Veterinarybiologybusiness.industrytransmission04 agricultural and veterinary sciencesFasciola hepaticabiology.organism_classificationTransmission (mechanics)Vector (epidemiology)lcsh:SF600-1100Veterinary ScienceLivestockepidemiologyvery high altitudebusinesshuman hyperendemicFrontiers in Veterinary Science
researchProduct

Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on t…

1996

Bone morphogenetic protein-6 (BMP-6) belongs to the family of TGF-beta-related growth factors. In the developing epidermis, expression of BMP-6 coincides with the onset of stratification. Expression persists perinatally but declines after day 6 postpartum, although it can still be detected in adult skin by reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. We constitutively overexpressed BMP-6 in suprabasal layers of interfollicular epidermis in transgenic mice using a keratin 10 promoter. All mice expressing the transgene developed abnormalities in the skin, indicating an active transgene-derived factor. Depending on the pattern of transgene expression, the effects on proli…

Bone Morphogenetic Protein 6Cellular differentiationTransgenemedicine.medical_treatmentMice TransgenicHuman skinIntegrin alpha6BiologyBone morphogenetic proteinMiceDermisAntigens CDmedicineAnimalsHumansPsoriasisAcanthosis NigricansRNA MessengerPromoter Regions GeneticSkinEpidermis (botany)Growth factorStomachMouth MucosaGene Expression Regulation DevelopmentalCell DifferentiationKeratosisArticlesCell BiologyKeratin-10Cell biologyBone morphogenetic protein 6medicine.anatomical_structureAnimals NewbornEpidermal CellsBone Morphogenetic ProteinsImmunologyKeratinsEpidermisCell DivisionJournal of Cell Biology
researchProduct

Pertussis in adults with persistent cough: a prospective follow up study in primary care.

2009

Despite high coverage of pertussis vaccine, B. pertussis has remained endemic and adults are recognized as reservoir for infection among incompletely immunized infants. Between November 15th 2004 and November 14th 2006, 37 general practitioners, attending 56,658 adults, recruited all patients with persistent cough. A diagnosis of pertussis was considered in those with an unexplained cough, lasting 14 or more days and a positive polymerase chain reaction (PCR) or enzyme-linked immunosorbent assay (ELISA) IgG anti-Pertussis Toxin (PT). During the period of the study 86 patients presented with persistent cough (106 cases per 100,000 person-years). According to laboratory criteria, 35% were cla…

Bordetella pertussismedicine.medical_specialtyImmunologyWhooping-cough-epidemiologyPharmaceutical SciencePrimary careHigh coverageBordetella pertussisAntibodiesInternal medicineDrug DiscoveryPersistent coughMedicineAdultsPrimary Carebiologybusiness.industryIncidence (epidemiology)Follow up studiesbiology.organism_classificationInfectious DiseasesImmunologybiology.proteinPertussis vaccineAntibodybusinessmedicine.drug
researchProduct

Efficacy of Acellular Pertussis Vaccine in Early Childhood After Household Exposure

1996

Objective. —To evaluate the efficacy of a three-dose primary vaccination with a diphtheria-tetanus tricomponent acellular pertussis vaccine against "typical" pertussis, defined as a spasmodic cough of 21 days or longer with confirmation of Bordetella pertussis infection by culture or serology. Design. —Passive monitoring for suspected first household (index) cases of typical pertussis in six areas in Germany comprising 22 505 children vaccinated with study vaccine at 3, 4, and 5 months of age. Blinded, prospective follow-up of household contacts of index cases for incidence and progression of pertussis. Setting. —Six areas in Germany with a high incidence of pertussis. Subjects. —Four hundr…

Bordetella pertussismedicine.medical_specialtyPediatricsbiologybusiness.industryIncidence (epidemiology)General MedicineEnvironmental exposurebiology.organism_classificationmedicine.diseaseVaccine efficacyVaccinationImmunizationEpidemiologyImmunologyMedicinebusinessWhooping coughJAMA: The Journal of the American Medical Association
researchProduct

Helicobacter pyloriinfection among children with gastrointestinal symptoms: a high prevalence of infection among patients with reflux oesophagitis

2007

Aim: To investigate the link between H.pylori infection and dyspepsia in children, and association with reflux oesophagitis. Patients and Methods: H.pylori status was detected by rapid urease test and/or culture in 130 consecutive symptomatic children coming for upper gastrointestinal endoscopy: 40 – aged 8–12 years (55% boys); 90 – aged 13–18 years (21% boys). Endoscopic findings were analyzed. H.pylori prevalence in the age group 8–12 years was compared to the prevalence among 55 asymptomatic children, aged 7–12 years (13C–urea breath test). Statistical analysis: χ2 test, Fisher's test, and logistic regression analysis. Results: The prevalence of H.pylori infection among patients with gas…

Breath testmedicine.medical_specialtybiologymedicine.diagnostic_testbusiness.industryRapid urease testGeneral MedicineHelicobacter pyloribiology.organism_classificationmedicine.diseaseLogistic regressionAsymptomaticGastroenterologyEl NiñoInternal medicinePediatrics Perinatology and Child HealthEpidemiologymedicinemedicine.symptombusinessEsophagitisActa Paediatrica
researchProduct

Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varice…

2016

Background Varicella is a highly infectious disease with a significant public health and economic burden, which can be prevented with childhood routine varicella vaccination. Vaccination strategies differ by country. Some factors are known to play an important role (number of doses, coverage, dosing interval, efficacy and catch-up programmes), however, their relative impact on the reduction of varicella in the population remains unclear. This paper aims to help policy makers prioritise the critical factors to achieve the most successful vaccination programme with the available budget. Methods Scenarios assessed the impact of different vaccination strategies on reduction of varicella disease…

Budgets0301 basic medicineMalePediatricsNational Health ProgramsNational Health ProgramDiseaseVaricella0302 clinical medicineChickenpoxEpidemiology030212 general & internal medicineChildChickenpox Vaccineeducation.field_of_studyChickenpoxlcsh:Public aspects of medicineImmunization ProgramVaccinationvirus diseasesCoverage; Dosing interval; Efficacy; Routine varicella vaccination impact; VaricellaVaccinationItalyBudgetDosing intervalFemalePublic HealthResearch ArticleHumanmedicine.medical_specialtyCoverageAdolescentEfficacy030106 microbiologyPopulationSocio-culturaleVaccines AttenuatedMass VaccinationRoutine varicella vaccination impactChickenpox Vaccine03 medical and health sciencesCoverage; Dosing interval; Efficacy; Routine varicella vaccination impact; Varicella; Public Health Environmental and Occupational HealthmedicineHumansDosingeducationImmunization Programsbusiness.industryEnvironmental and Occupational HealthPublic Health Environmental and Occupational Healthlcsh:RA1-1270Models Theoreticalmedicine.diseaseVaccine efficacybusinessBMC Public Health
researchProduct

Atmospheric dust, early cases, and localized meningitis epidemics in the African meningitis belt: an analysis using high spatial resolution data.

2018

8 pages; International audience; Background : Bacterial meningitis causes a high burden of disease in the African meningitis belt, with regular seasonal hyperendemicity and sporadic short, but intense, localized epidemics during the late dry season occurring at a small spatial scale [i.e., below the district level, in individual health centers (HCs)]. In addition, epidemic waves with larger geographic extent occur every 7–10 y. Although atmospheric dust load is thought to be an essential factor for hyperendemicity, its role for localized epidemics remains hypothetic.Objectives : Our goal was to evaluate the association of localized meningitis epidemics in HC catchment areas with the dust lo…

Burden of disease010504 meteorology & atmospheric sciencesHealth Toxicology and MutagenesisMeningitis Meningococcal01 natural sciences03 medical and health sciences0302 clinical medicine[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesEnvironmental healthBurkina FasoHigh spatial resolutionmedicineHumans030212 general & internal medicineEpidemics0105 earth and related environmental sciencesIncidence (epidemiology)IncidenceResearchPublic Health Environmental and Occupational HealthDustAtmospheric dustmedicine.disease3. Good healthGeography[SDU.STU.CL]Sciences of the Universe [physics]/Earth Sciences/ClimatologyBacterial meningitis[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieSeasonsAfrican meningitis beltMeningitis
researchProduct

Cardiovascular disease burden: Italian and global perspectives

2021

Background Cardiovascular disease (CVD) is still the leading cause of death worldwide, responsible for an estimated 17.8 million deaths globally in 2017, accounting for 31.8% of all deaths. In this review, we aim to provide an updated overview of CVD burden from an Italian and a global perspective. Methods Crude and age-standardized incidence and prevalence, as well as age-standardized mortality rate and morbidity rate (expressed as disability-adjusted life years - DALYs), of different cardiovascular conditions, derived from the Global Burden of Disease Injuries, and Risk Factors Study (GBD) 2017, were reported and compared between Italy and the world. Results Crude prevalence of CVD in Ita…

Burden of diseasemedicine.medical_specialtybusiness.industryEpidemiologyIncidence (epidemiology)Mortality rateDiseaseGlobal HealthGlobal Burden of DiseaseCardiovascular diseases; Epidemiology; ItalyLife ExpectancyCardiovascular diseasesItalyEnvironmental healthEpidemiologymedicineHumansCardiology and Cardiovascular MedicineIschemic heartbusinessDisease burdenAgedCause of death
researchProduct

Trends in Prevalence of Blindness and Distance and Near Vision Impairment Over 30 Years and Contribution to the Global Burden of Disease in 2020

2020

Background: The Vision Loss Expert Group and Global Burden of Disease Study have extensively updated estimates of global vision loss burden in 2020, temporal changeover 3 decades and forecasts for 2050. Methods: A systematic review and meta-analysis was conducted of population-based datasets relevant to vision impairment (VI) from January 1980 to October 2018. Hierarchical models were fitted to estimate 2020 prevalence (with 95% uncertainty intervals, UI) of (1) mild VI (presenting visual acuity [PVA] 6/12). Findings: In 2020, an estimated 43.2 million (95% UI: 37.5-48.2 million; 55% female) people were blind, 295.3 (95% UI 267.0-325.5) million had MSVI, 257.3 (95% UI 232.2-284.7) million h…

Burden of diseasemedicine.medical_specialtyeducation.field_of_studyVisual acuityBlindnessbusiness.industryPopulationGlobal visionmedicine.diseaseExpert groupNear visionEpidemiologyMedicinemedicine.symptombusinesseducationDemographySSRN Electronic Journal
researchProduct